Bormioli Pharma (PRIVATE.BORMIOLI)

Overall impact
C (42)

Commentary

Bormioli Pharma is an average overall performer. With a 'C' rating of 42.1 for overall impact (26th percentile compared to all companies), Bormioli Pharma ranks 72nd out of 94 industry peers, behind IFCO Systems, PaperWorks, Aptar and 68 others, and ahead of Ranpak Holdings, BALL, Crown Holdings and 19 others. On top material causes for Bormioli Pharma's industry (Industrial Goods), Bormioli Pharma performs well in Technology Innovation (80.6 score) and performs poorly in Terrestrial Biodiversity (31.9 score), Conflict Free Mineral Production (15.2), Lgbtq Equality (15.3) and 8 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.BORMIOLI
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1824
Employees
1,500
Sector
Materials
Industry
Containers & Packaging
Sub-industry
Paper & Plastic Packaging Products & Materials
SASB industry
Containers & Packaging
Headquarters
Italy
Share classes
PRIVATE.BORMIOLI
Description
Manufacturer of primary packaging products catering to the pharmaceutical sector. The company offers a wide range of childproof and tamper-evident caps and bottles made of PET, PE, PP, and glass fibers. This product range provides safe and efficient packaging, protecting drugs from deterioration. Additionally, it helps to prolong medications' stability and provide accurate dosing.
Material causes
Ethos considers the following causes material for Bormioli Pharma, based on its industry sub-industry Paper & Plastic Packaging Products & Materials. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.